|
|
|
|
|
|
|
|
|
|
|
|
|
07.05.25 - 13:33
|
Orogen Therapeutics Announces Expansion of Board with Biopharma Leaders Mikael Dolsten and Dieter Weinand as Independent Non-Executive Directors. (Business Wire)
|
|
|
WOBURN, Mass.--(BUSINESS WIRE)--Orogen Therapeutics, Inc., a private drug discovery company utilizing its proprietary, AI-enabled DNA encoded library (DEL) technology to identify novel chemical matter against medically and commercially attractive drug targets, today announced the expansion of its Board of Directors with Independent Non-Executive biopharma leaders Mikael Dolsten, M.D., Ph.D., prior Chief Scientific Officer and President of Research and Development at Pfizer, and Dieter Weinand, M.S., former CEO and chairman of the board of Bayer Pharmaceuticals AG. Dr. Dolsten will also serve as Chairman of the Orogen Board. Dr. Dolsten and Mr. Weinand join co-founding investors Marijn Dekkers, Chairman of Novalis LifeSciences, former CEO of Bayer AG, CEO of Thermo Fisher Scientific, and Chairman of Unilever, and Phil Austin, Managing Partner of Anterra Capital, along with Dr. Mark Pykett, CEO of the company, on the Orogen Board.
“We are thrilled to have Mikael Dolsten and Dieter Weinand join the Orogen ...
|
|
|
06.05.25 - 23:03
|
Triple Flag Announces Record Quarterly Cash Flow and Strong Q1 2025 Results (Business Wire)
|
|
|
TORONTO--(BUSINESS WIRE)--Triple Flag Precious Metals Corp. (with its subsidiaries, “Triple Flag” or the “Company”) (TSX: TFPM, NYSE: TFPM) announced its results for the first quarter of 2025 and declared a dividend of US$0.055 per common share to be paid on June 16, 2025. Unless otherwise indicated, all amounts are expressed in US dollars.
“Our operating cash flow per share increased by 74% year-over-year in the first quarter of 2025, underpinned by strong performance from Northparkes and Cerro Lindo. This record start to the year has positioned us well, and guidance for 2025 of 105,000 to 115,000 GEOs remains unchanged,” commented Sheldon Vanderkooy, CEO. “Triple Flag has also maintained a solid pace of acquisitions through the last four months, including the precious metals streams on the Arcata and Azuca mines in Peru, and more recently, the proposed acquisition of Orogen Royalties and its 1.0% NSR royalty on the Expanded Silicon gold project in Nevada. Expanded Silicon is a top-tier gol...
|
|
|
|
|
|
|
|
|
|
|
|
|
22.04.25 - 13:06
|
Triple Flag Proposes to Acquire Orogen Royalties Inc. (Business Wire)
|
|
|
Altius agrees to request from Orogen to enter a conditional Voting Support Agreement
ST. JOHN'S, Newfoundland--(BUSINESS WIRE)--$ALS.TO #Orogen--Altius Minerals Corporation (TSX: ALS) (OTCQX: ATUSF) Altius Minerals Corporation (“Altius”) reports that Orogen Royalties Inc. (“Orogen”), of which it is a major shareholder with 39,557,960 Orogen shares, has announced a definitive agreement with Triple Flag Precious Metals Corp. (“Triple Flag”) whereby Triple Flag will acquire all of the issued and outstanding common shares of Orogen for total consideration of approximately $421 million or $2.00 per Orogen share, comprised of approximately $171.5 million in cash, $171.5 million in Triple Flag shares, and shares of a new company (“Orogen Spinco”) with an implied value of approximately $78 million. Orogen requested that Altius enter into a Voting Support Agreement in respect of the transaction and it has done so subject to certain conditions including an ability to rescind its support in the even...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
